Log in to save to my catalogue

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in ch...

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in ch...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_500806

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

About this item

Full title

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

Publisher

London: Nature Publishing Group UK

Journal title

Leukemia, 2017-05, Vol.31 (5), p.1108-1116

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Recent studies suggest that a proportion of chronic myeloid leukemia (CML) patients in deep molecular remission can discontinue the tyrosine kinase inhibitor (TKI) treatment without disease relapse. In this multi-center, prospective clinical trial (EURO-SKI, NCT01596114) we analyzed the function and phenotype of T and NK cells and their relation to...

Alternative Titles

Full title

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_swepub_ki_se_500806

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_500806

Other Identifiers

ISSN

0887-6924,1476-5551

E-ISSN

1476-5551

DOI

10.1038/leu.2016.360